BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1059 related articles for article (PubMed ID: 26664105)

  • 1. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation.
    Jo YS; Yoon HI; Kim DK; Yoo CG; Lee CH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():101-107. PubMed ID: 29317814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.
    Casanova C; Marin JM; Martinez-Gonzalez C; de Lucas-Ramos P; Mir-Viladrich I; Cosio B; Peces-Barba G; Solanes-García I; Agüero R; Feu-Collado N; Calle-Rubio M; Alfageme I; de Diego-Damia A; Irigaray R; Marín M; Balcells E; Llunell A; Galdiz JB; Golpe R; Lacarcel C; Cabrera C; Marin A; Soriano JB; Lopez-Campos JL; Soler-Cataluña JJ; de-Torres JP;
    Chest; 2015 Jul; 148(1):159-168. PubMed ID: 25612228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations.
    García-Sidro P; Naval E; Martinez Rivera C; Bonnin-Vilaplana M; Garcia-Rivero JL; Herrejón A; Malo de Molina R; Marcos PJ; Mayoralas-Alises S; Ros JA; Valle M; Esquinas C; Barrecheguren M; Miravitlles M
    Respir Med; 2015 Dec; 109(12):1546-52. PubMed ID: 26542727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations.
    Avriel A; Rozenberg D; Raviv Y; Heimer D; Bar-Shai A; Gavish R; Sheynin J; Douvdevani A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3153-3161. PubMed ID: 28003743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining prognosis in acute exacerbation of COPD.
    Flattet Y; Garin N; Serratrice J; Perrier A; Stirnemann J; Carballo S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():467-475. PubMed ID: 28203070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the GOLD 2013 classification in predicting exacerbations and mortality in Taiwanese patients with chronic obstructive pulmonary disease.
    Chen CZ; Ou CY; Hsu CH; Hsiue TR
    J Formos Med Assoc; 2015 Dec; 114(12):1258-66. PubMed ID: 25676673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of acute deterioration in health status visit among COPD patients by monitoring COPD assessment test score.
    Pothirat C; Chaiwong W; Limsukon A; Deesomchok A; Liwsrisakun C; Bumroongkit C; Theerakittikul T; Phetsuk N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():277-82. PubMed ID: 25678783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of a remote support program on quality of life and evolution of disease in COPD patients with frequent exacerbations.
    Alcazar B; de Lucas P; Soriano JB; Fernández-Nistal A; Fuster A; González-Moro JM; Arnedillo A; Sidro PG; de Los Monteros MJ
    BMC Pulm Med; 2016 Nov; 16(1):140. PubMed ID: 27821164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
    Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
    Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Course of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary disease.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de los Monteros MJ; Molina J
    Health Qual Life Outcomes; 2013 Aug; 11():147. PubMed ID: 23987232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
    Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of brief questionnaires of health-related quality of life (Airways Questionnaire 20 and Clinical COPD Questionnaire) to predict exacerbations in patients with asthma and COPD.
    Blanco-Aparicio M; Vázquez I; Pita-Fernández S; Pértega-Diaz S; Verea-Hernando H
    Health Qual Life Outcomes; 2013 May; 11():85. PubMed ID: 23706146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.
    Fernández-Villar A; López-Campos JL; Represas Represas C; Marín Barrera L; Leiro Fernández V; López Ramírez C; Casamor R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():961-7. PubMed ID: 26028969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the COPD Assessment Test (CAT) and the Clinical COPD Questionnaire (CCQ) in a Clinical Population.
    Sundh J; Ställberg B; Lisspers K; Kämpe M; Janson C; Montgomery S
    COPD; 2016; 13(1):57-65. PubMed ID: 26367315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the COPD severity score for use in primary care: the NEREA study.
    Miravitlles M; Llor C; de Castellar R; Izquierdo I; Baró E; Donado E
    Eur Respir J; 2009 Mar; 33(3):519-27. PubMed ID: 19164354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease.
    Miravitlles M; Huerta A; Valle M; García-Sidro P; Forné C; Crespo C; López-Campos JL
    Int J Chron Obstruct Pulmon Dis; 2015; 10():367-77. PubMed ID: 25733826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units.
    Sundh J; Johansson G; Larsson K; Lindén A; Löfdahl CG; Sandström T; Janson C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2327-34. PubMed ID: 26604732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.